Literature DB >> 23462935

Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".

Manthena V S Varma, Yurong Lai, Bo Feng, John Litchfield, Theunis C Goosen, Arthur Bergman.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23462935     DOI： 10.1007/s11095-013-0987-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  7 in total

1.  Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.

Authors:  Manthena V S Varma; Yurong Lai; Bo Feng; John Litchfield; Theunis C Goosen; Arthur Bergman
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

2.  The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling.

Authors:  Motohiro Kato; Yoshihisa Shitara; Hitoshi Sato; Kunihiro Yoshisue; Masaru Hirano; Toshihiko Ikeda; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2008-05-16       Impact factor: 4.200

3.  Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters.

Authors:  Na Li; Pratap Singh; Kathy M Mandrell; Yurong Lai
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

4.  Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.

Authors:  Hannah M Jones; Hugh A Barton; Yurong Lai; Yi-An Bi; Emi Kimoto; Sarah Kempshall; Sonya C Tate; Ayman El-Kattan; J Brian Houston; Aleksandra Galetin; Katherine S Fenner
Journal:  Drug Metab Dispos       Date:  2012-02-16       Impact factor: 3.922

5.  Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

Authors:  Edmund Lee; Stephen Ryan; Bruce Birmingham; Julie Zalikowski; Ruth March; Helen Ambrose; Rachael Moore; Caroline Lee; Yusong Chen; Dennis Schneck
Journal:  Clin Pharmacol Ther       Date:  2005-10       Impact factor: 6.875

6.  Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide.

Authors:  Manthena V S Varma; Yurong Lai; Emi Kimoto; Theunis C Goosen; Ayman F El-Kattan; Vikas Kumar
Journal:  Pharm Res       Date:  2013-01-10       Impact factor: 4.200

7.  Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.

Authors:  Emi Kimoto; Kenta Yoshida; Larissa M Balogh; Yi-An Bi; Kazuya Maeda; Ayman El-Kattan; Yuichi Sugiyama; Yurong Lai
Journal:  Mol Pharm       Date:  2012-11-02       Impact factor: 4.939
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.